companydata.dkBIOSYNTIA ApS: Financial statements 2013
CVR: 34892970
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 389,094 and a net result of DKK -27,777. Equity amounted to DKK 52,223. The solvency ratio was 10.9%.
- Gross Profit
- 389,094 kr.
- Profit/Loss
- -27,777 kr.
- Equity
- 52,223 kr.
- Total Assets
- 478,545 kr.
Find more companies like BIOSYNTIA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
As of December 5, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of BIOSYNTIA ApS.
As of December 5, 2013, RVT REVISIONSTJENESTEN A/S has stepped down as auditor of BIOSYNTIA ApS.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees. In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity amounted to DKK 32,860,576.